Paris, Munich
After a successful First Closing of Kurma‘s new Biofund III at the end of last year, the Venture Capital firm today announced the launch of its Munich operations headed by newly appointed partner Dr. Peter Neubeck. Founded in 2009, Kurma Partners invests in innovation in healthcare and biotechnology, from pre-seed to growth capital, from its third fund generation.
see PDF for full press release